DKSH MALAYSIA SDN BHD — Celecoxib Importer Profile
Pharmaceutical Importer · #19 buyer for Celecoxib · $645.1K import value · 16 shipments · MALAYSIA · DGFT Verified
DKSH MALAYSIA SDN BHD is the #19 importer of Celecoxib from India with $645.1K in import value and 16 verified shipments. DKSH MALAYSIA SDN BHD holds a 0.6% market share in Celecoxib imports based in MALAYSIA. The company sources from 1 verified supplier across 15 formulations shipped to 1 country.
DKSH MALAYSIA SDN BHD — Celecoxib Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Celecoxib to DKSH MALAYSIA SDN BHD?
Verified from 16 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TORRENT PHARMACEUTICALS LIMITED | $645.1K | 16 | 100.0% |
DKSH MALAYSIA SDN BHD sources Celecoxib from 1 verified Indian supplier based on 16 customs records. The primary supplier is TORRENT PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
Where Does DKSH MALAYSIA SDN BHD Import Celecoxib To?
Destination countries from 16 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALAYSIA | $645.1K | 16 | 100.0% |
DKSH MALAYSIA SDN BHD imports Celecoxib to 1 country. The primary destination is MALAYSIA receiving 100.0% of shipments worth $645.1K.
What Celecoxib Formulations Does DKSH MALAYSIA SDN BHD Import?
| Formulation | Value | Shipments |
|---|---|---|
| OTHERS - TORCOXIB 200MG CAPSULES CELECOXIB 200MG 1 NOS = SIZE 3X10 CAPS | $100.0K | 2 |
| TORCOXIB 200MG CAPSULES (CELECOXIB 200MG | $50.0K | 1 |
| Torcoxib 200 mg Capsules ( CELECOXIB 200MG ) BATCH NO -BRG4L008,MFG DT NOV-2024,EXP DT OCT-2026 (3X10CAP) | $50.0K | 1 |
| TORCOXIB 200MG CAPSULES (CELECOXIB 200MG) (NOS = 3X10 CAPSULES) | $50.0K | 1 |
| TORCOXIB 200MG CAPSULES (CELECOXIB 200MG) (NOS=3X10 CAPSULES)NOS | $50.0K | 1 |
| TORCOXIB 200MG CAPSULES (CELECOXIB 200MG) (ACT. QTY. 8640 X 3 X 10 CAPSULES)NOS | $50.0K | 1 |
| OTHER - TORCOXIB 200MG CAPSULES (CELECOXIB 200MG) (ACT QTY. 9216 X3X10 TAB) | $50.0K | 1 |
| OTHER-TORCOXIB 200 MG CAPSULES (CELECOXIB 200 MG) (QTY. 14976 X3X10 CAPSULES) | $50.0K | 1 |
| OTHER-TORCOXIB 200 MG CAPSULES ( CELECOXIB 200 MG )NOS SIZE 3 X 10 CAPSULES | $50.0K | 1 |
| TORCOXIB 200MG CAPSULES (CELECOXIBCAPSULES 200MG) (NOS=3X10 CAPSULES ) | $50.0K | 1 |
DKSH MALAYSIA SDN BHD imports 15 distinct Celecoxib formulations from India. The top formulation is OTHERS - TORCOXIB 200MG CAPSULES CELECOXIB 200MG 1 NOS = SIZ with 2 shipments worth $100.0K.
Who Are the Top Buyers of Celecoxib from India and How Much Does DKSH MALAYSIA SDN BHD Import?
India exported $35.0M worth of Celecoxib through 4,880 shipments from 326 suppliers to 112 countries, serving 781 buyers globally. DKSH MALAYSIA SDN BHD imports $645.1K of this total, accounting for 0.6% of India's Celecoxib exports with 16 shipments from MALAYSIA. This is verified from 16 customs shipment records covering 15 distinct formulations.
What Is the Average Order Value for DKSH MALAYSIA SDN BHD's Celecoxib Imports?
DKSH MALAYSIA SDN BHD's average Celecoxib order value is $40.3K per consignment, based on 16 shipments totaling $645.1K. DKSH MALAYSIA SDN BHD is based in MALAYSIA and ranks #19 among all Celecoxib importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Celecoxib to DKSH MALAYSIA SDN BHD?
DKSH MALAYSIA SDN BHD sources Celecoxib from 1 verified Indian supplier: TORRENT PHARMACEUTICALS LIMITED ($645.1K, 100.0%). This is based on 16 customs records.
How Does DKSH MALAYSIA SDN BHD Compare to Other Celecoxib Importers?
DKSH MALAYSIA SDN BHD ranks #19 among 781 Celecoxib importers from India with a 0.6% market share. The top 3 importers are CIPLA USA INC UPS SUPPLY CHAIN SOLU ($5.7M), J. KNIPPER & COMPANY ($4.3M), NORTHSTAR DISTRIBUTION CENTER 8912 ($3.5M). DKSH MALAYSIA SDN BHD processed 16 shipments from MALAYSIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Celecoxib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Celecoxib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: DKSH MALAYSIA SDN BHD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as DKSH MALAYSIA SDN BHD's capped import value divided by total capped export value for Celecoxib across all Indian exporters.
- 5.Verified Records: This page is backed by 16 individual customs records matching DKSH MALAYSIA SDN BHD importing Celecoxib, covering 15 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 112+ countries, 781+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Celecoxib Import Data for DKSH MALAYSIA SDN BHD
Access order-level details, pricing data, supplier connections, and competitive analysis for DKSH MALAYSIA SDN BHD's Celecoxib imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DKSH MALAYSIA SDN BHD
Company Profile
Multiple products · $0 total trade · Multiple categories
DKSH MALAYSIA SDN BHD × Celecoxib
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for DKSH MALAYSIA SDN BHD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Celecoxib. For current order-level data, contact TransData Nexus.